# SCYNEXIS, Inc. (SCYX) · Edgar & Edgarette company card

> Scynexis (SCYX) grew revenue 450% in FY2025 to $21 million, operating margin -78.0% against a -3.8% median for pharmaceutical preparations, equity 83.6% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1178253 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/SCYX) · [JSON](https://www.pops4.com/boards/company/SCYX.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $21M |
| Revenue growth, 1 year | 449.9% |
| Revenue growth per year | 11.8% |
| Operating margin | -78.0% (prior year -990.8%) |
| Net margin | -41.8% |
| Operating cash flow | −$5M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $21M |
| Long-term debt | — |
| Total assets | $59M |
| Total equity | $49M |
| Equity ÷ assets | 83.6% |
| Return on equity | -17.4% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -13.88 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative; operating loss: a margin of -78.0% in FY2025; revenue is hard to predict: its 80% range is ±53%

## Edgarette's reading

Exposure: revenue $20.6M (FY2025). Experience: revenue up 449.9% on the year, up 11.8% a year over 4 years; operating margin -78.0%, up from -990.8%. Soundness: equity 83.6% of assets, return on equity -17.4%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $39.9M and $128.8M next year (method v4.1: its own 1-year record of growth weighed at 0% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $36.8M to $140.0M. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin -78.0% against a -3.8% median; growth 449.9% against 13.7%.

Range logged 2026-09-25, receipt 7fb8cce2a806f528, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-09-22 ([filing](https://www.sec.gov/Archives/edgar/data/1178253/000117825326000035/0001178253-26-000035-index.htm))

## Recent filings

- 8-K · filed 2026-09-28 · 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1178253/000117825326000037/0001178253-26-000037-index.htm)
- 8-K · filed 2026-09-22 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1178253/000117825326000035/0001178253-26-000035-index.htm)
- 8-K · filed 2026-09-10 · 5.02 Departure or Election of Directors; Appointment of Officers; 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1178253/000117825326000031/0001178253-26-000031-index.htm)
- 10-Q · filed 2026-08-10 · [filing](https://www.sec.gov/Archives/edgar/data/1178253/000117825326000027/0001178253-26-000027-index.htm)
- 8-K · filed 2026-06-26 · 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1178253/000117825326000021/0001178253-26-000021-index.htm)
- 8-K · filed 2026-05-29 · 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1178253/000117825326000017/0001178253-26-000017-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001178253.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1178253

## Cite

POPS4, Edgar & Edgarette: SCYNEXIS, Inc. (SCYX) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/SCYX. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.